North America Huntingtons Disease Treatment Market Size & Outlook
North America huntingtons disease treatment market, 2018-2030 (US$M)
Related Markets
North America huntingtons disease treatment market highlights
- The North America huntingtons disease treatment market generated a revenue of USD 338.7 million in 2023.
- The market is expected to grow at a CAGR of 21.1% from 2024 to 2030.
- In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2023.
- Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 338.7 million |
| Market revenue in 2030 | USD 1,292.7 million |
| Growth rate | 21.1% (CAGR from 2023 to 2030) |
| Largest segment | Symptomatic treatment |
| Fastest growing segment | Symptomatic Treatment |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Symptomatic Treatment |
Other key industry trends
- In terms of revenue, North America region accounted for 78.0% of the global huntingtons disease treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 29.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Huntingtons Disease Treatment Market Scope
Huntingtons Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America huntingtons disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.
Symptomatic treatment was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.
North America region accounts for the largest market share owing to high disease burden, availability of products for symptom management, and favorable government initiatives for developing disease treatment. Major players, such as H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd., support market growth by introducing symptom management products.
Moreover, this region held a major market share, especially the U.S., due to increasing R&D efforts for Huntington’s Disease (HD) treatment. This has driven U.S.-based firms to make considerable investments in development of novel drugs.
For instance, in December 2021, Neurocrine Biosciences, Inc. announced the positive results of phase 3 clinical trial on Ingrezza (valbenazine) as once daily treatment for chorea associated with HD in the U.S. The company plans to submit supplemental NDA in 2022.
Reasons to subscribe to North America huntingtons disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America huntingtons disease treatment market databook
-
Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America huntingtons disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America huntingtons disease treatment market size, by country, 2018-2030 (US$M)
North America Huntingtons Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
